OHR PHARMACEUTICAL
OHR Pharmaceutical is a development-stage biotechnology company that focuses on the development of products for the treatment of cancer cachexia (multi-symptom wasting disorder) and wet- age-related macular degeneration. It was founded in 2009 and is headquartered in New York, New York.
OHR PHARMACEUTICAL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2009-01-01
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.ohrpharmaceutical.com
Total Employee:
1+
Status:
Active
Contact:
(212) 682-8452
Email Addresses:
[email protected]
Total Funding:
47.92 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Domain Not Resolving Google Maps GoDaddy DNS Google Google Cloud OpenResty Google Adsense
Similar Organizations
Adamas Pharmaceuticals
Adamas Pharmaceuticals develops controlled release combination therapeutics for infectious diseases and central nervous system disorders.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
IVERIC bio
IVERIC bio is a biopharmaceutical company developing novel therapies for age-related macular degeneration.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Ultragenyx Pharmaceutical
Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2019-01-03 | NeuBase Therapeutics | NeuBase Therapeutics acquired by OHR Pharmaceutical | N/A |
Official Site Inspections
http://www.ohrpharmaceutical.com
- Host name: a2aa9ff50de748dbe.awsglobalaccelerator.com
- IP address: 15.197.148.33
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
